Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tomivosertib + Paclitaxel in Advanced Breast Cancer
NCT04261218Phase 1Completed
- Sponsor
- Translational Research In Oncology
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tomivosertib in breast cancer (2 arms), sponsored by Translational Research In Oncology. Primary endpoints: Number of Patients with Adverse Events and Change from Baseline Pharmacodynamic Effects at Day 14. Started Aug 2020; status: completed.
02
Drugs
tomivosertib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04261218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04261218.